| 标题 |
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Sandra M. Swain; David Miles; Sung‐Bae Kim; Young‐Hyuck Im; Seock‐Ah Im; et al 出版日期:2020-03-12 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)